Contrast  ||| S:0 E:9 ||| NN
enhanced  ||| S:9 E:18 ||| VBN
ultrasound  ||| S:18 E:29 ||| NN
in  ||| S:29 E:32 ||| IN
renal  ||| S:32 E:38 ||| JJ
diseases  ||| S:38 E:47 ||| NNS
Contrast-enhanced  ||| S:47 E:65 ||| JJ
ultrasound  ||| S:65 E:76 ||| NN
( ||| S:76 E:77 ||| -LRB-
CEUS ||| S:77 E:81 ||| NNP
)  ||| S:81 E:83 ||| -RRB-
is  ||| S:83 E:86 ||| VBZ
one  ||| S:86 E:90 ||| CD
of  ||| S:90 E:93 ||| IN
the  ||| S:93 E:97 ||| DT
most  ||| S:97 E:102 ||| RBS
interesting  ||| S:102 E:114 ||| JJ
and  ||| S:114 E:118 ||| CC
promising  ||| S:118 E:128 ||| JJ
clinical  ||| S:128 E:137 ||| JJ
applications  ||| S:137 E:150 ||| NNS
of  ||| S:150 E:153 ||| IN
imaging  ||| S:153 E:161 ||| NN
and  ||| S:161 E:165 ||| CC
ultrasound ||| S:165 E:175 ||| NN
.  ||| S:175 E:177 ||| .
Thanks  ||| S:177 E:184 ||| NNS
to  ||| S:184 E:187 ||| TO
the  ||| S:187 E:191 ||| DT
absence  ||| S:191 E:199 ||| NN
of  ||| S:199 E:202 ||| IN
ionizing  ||| S:202 E:211 ||| JJ
radiation ||| S:211 E:220 ||| NN
,  ||| S:220 E:222 ||| ,
the  ||| S:222 E:226 ||| DT
lack  ||| S:226 E:231 ||| NN
of  ||| S:231 E:234 ||| IN
nephrotoxicity  ||| S:234 E:249 ||| NN
and  ||| S:249 E:253 ||| CC
low  ||| S:253 E:257 ||| JJ
cost  ||| S:257 E:262 ||| NN
it  ||| S:262 E:265 ||| PRP
has  ||| S:265 E:269 ||| VBZ
the  ||| S:269 E:273 ||| DT
potential  ||| S:273 E:283 ||| JJ
to  ||| S:283 E:286 ||| TO
become  ||| S:286 E:293 ||| VB
a  ||| S:293 E:295 ||| DT
reference  ||| S:295 E:305 ||| NN
in  ||| S:305 E:308 ||| IN
imaging  ||| S:308 E:316 ||| NN
of  ||| S:316 E:319 ||| IN
the  ||| S:319 E:323 ||| DT
kidney ||| S:323 E:329 ||| NN
.  ||| S:329 E:331 ||| .
This  ||| S:331 E:336 ||| DT
review ||| S:336 E:342 ||| NN
,  ||| S:342 E:344 ||| ,
besides  ||| S:344 E:352 ||| IN
providing  ||| S:352 E:362 ||| VBG
a  ||| S:362 E:364 ||| DT
brief  ||| S:364 E:370 ||| JJ
description  ||| S:370 E:382 ||| NN
of  ||| S:382 E:385 ||| IN
the  ||| S:385 E:389 ||| DT
proper  ||| S:389 E:396 ||| JJ
methodology ||| S:396 E:407 ||| NN
,  ||| S:407 E:409 ||| ,
presents  ||| S:409 E:418 ||| VBZ
possible  ||| S:418 E:427 ||| JJ
applications  ||| S:427 E:440 ||| NNS
of  ||| S:440 E:443 ||| IN
CEUS  ||| S:443 E:448 ||| NNP
in  ||| S:448 E:451 ||| IN
nephrology  ||| S:451 E:462 ||| NN
and  ||| S:462 E:466 ||| CC
urology ||| S:466 E:473 ||| NN
,  ||| S:473 E:475 ||| ,
including  ||| S:475 E:485 ||| VBG
renal  ||| S:485 E:491 ||| JJ
ischemia ||| S:491 E:499 ||| NN
,  ||| S:499 E:501 ||| ,
the  ||| S:501 E:505 ||| DT
differential  ||| S:505 E:518 ||| JJ
diagnosis  ||| S:518 E:528 ||| NN
of  ||| S:528 E:531 ||| IN
cystic  ||| S:531 E:538 ||| NN
and  ||| S:538 E:542 ||| CC
solid  ||| S:542 E:548 ||| JJ
lesions ||| S:548 E:555 ||| NNS
,  ||| S:555 E:557 ||| ,
follow-up  ||| S:557 E:567 ||| JJ
of  ||| S:567 E:570 ||| IN
ablative  ||| S:570 E:579 ||| JJ
therapies ||| S:579 E:588 ||| NNS
,  ||| S:588 E:590 ||| ,
kidney  ||| S:590 E:597 ||| NN
trauma ||| S:597 E:603 ||| NN
,  ||| S:603 E:605 ||| ,
kidney  ||| S:605 E:612 ||| NN
transplant ||| S:612 E:622 ||| NN
,  ||| S:622 E:624 ||| ,
inflammatory  ||| S:624 E:637 ||| JJ
diseases ||| S:637 E:645 ||| NNS
,  ||| S:645 E:647 ||| ,
ischemic  ||| S:647 E:656 ||| JJ
nephropathy  ||| S:656 E:668 ||| NN
and  ||| S:668 E:672 ||| CC
vesicoureteral  ||| S:672 E:687 ||| JJ
reflux ||| S:687 E:693 ||| NN
.  ||| S:693 E:695 ||| .
